CF PharmTech prices HK$ 300.55 million H-share placement at HK$ 13.82 each

• CF PharmTech launched a best-efforts placing of 21,747,700 new H shares at HK$ 13.82 each under its general mandate.
• Deal size HK$ 300.55 million gross, HK$ 294.81 million net; pricing implies an 11.97% discount to the prior close.
• Shares equal 5.3% of issued share capital pre-transaction; 5.03% on an enlarged basis, excluding treasury shares.
• Closing targeted for Aug. 6, 2026, subject to Hong Kong listing approval and PRC regulatory clearances.
• Proceeds earmarked for R&D and pipeline development; remainder for complex inhalation products, working capital, general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12263166), on July 30, 2026, and is solely responsible for the information contained therein.